Fatal Pandoraea nosoerga infection after combined liver-lung transplantation for cystic fibrosis: a recontamination by the pre-transplantation strain

Eur J Clin Microbiol Infect Dis. 2021 Nov;40(11):2403-2406. doi: 10.1007/s10096-021-04235-0. Epub 2021 Apr 8.

Abstract

A 26-year-old girl with a longstanding colonization by Pandoraea nosoerga underwent liver-lung transplantation for cystic fibrosis (CF) in 2018. Her brother also suffering from CF was also colonized by P. nosoerga. Despite appropriate perioperative antibiotic therapy, she had post-transplant bacteremic pneumonia caused by extensively drug-resistant P. nosoerga. Drug repurposing was used to optimize treatment options. The cause of post-transplant contamination was studied by comparative whole-genome sequencing including pre- and post-transplant strains and her brother's strains. Post-transplant contamination appeared to be due to her own pre-transplant strain, emphasizing the urgent need to study and implement effective decontamination protocols before transplantation.

Keywords: Comparative genomic; Cystic fibrosis; Drug repurposing; Extensively drug-resistant bacteria; Pandoraea.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Burkholderiaceae / genetics
  • Burkholderiaceae / isolation & purification
  • Burkholderiaceae / physiology
  • Cystic Fibrosis / surgery*
  • Fatal Outcome
  • Female
  • Gram-Negative Bacterial Infections / drug therapy
  • Gram-Negative Bacterial Infections / microbiology*
  • Gram-Negative Bacterial Infections / mortality
  • Humans
  • Liver / surgery
  • Liver Transplantation / adverse effects*
  • Lung / microbiology
  • Lung / surgery
  • Lung Transplantation / adverse effects*
  • Postoperative Complications / drug therapy
  • Postoperative Complications / microbiology*
  • Postoperative Complications / mortality

Substances

  • Anti-Bacterial Agents